MESOBLAST LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.915 AUD | +1.67% |
|
+22.00% | +195.16% |
| Apr. 01 | ADRs End Higher; Connect Biopharma Climbs 26% | DJ |
| Mar. 28 | ADRs End Lower; NuCana Slides 15% | DJ |
Chart calendar Mesoblast Limited
e4580b0691a0403ab014717e2155f00.3hRzgz3Ptf74RyAXf_9Ur1w_uZB3sldElOgcS-RPVOo.rS0p20SkwJCwahVlHJon2D148sckgAQx5ZJkMp16ZYvvfzbzcaKFt7k-Uw~13cab77dcd9e538f76de8591f7b40beb
Upcoming events on Mesoblast Limited
Past events on Mesoblast Limited
| 2024-02-28 05:00 pm | Q2 2024 Earnings Call |
| 2024-02-28 04:54 pm | Q2 2024 Earnings Release |
| 2024-01-30 08:39 pm | December 2023 Sales and Revenue Release - Activities Report |
| 2023-12-04 | Rights Issue: 1 new share @ 0.3 AUD for 4 existing shares |
| 2023-11-27 08:00 pm | Annual General Meeting |
| 2023-10-30 06:02 pm | September 2023 Sales and Revenue Release - Activities Report |
| 2023-08-30 06:30 pm | Q4 2023 Earnings Call |
| 2023-08-30 06:20 pm | Q4 2023 Earnings Release |
| 2023-08-03 | Remestemcel-L FDA Update Call |
| 2023-07-30 07:49 pm | June 2023 Sales and Revenue Release - Activities Report |
| 2023-06-20 04:30 pm | Maxim Group Virtual Healthcare Conference |
| 2023-05-25 06:32 pm | Q3 2023 Earnings Release |
| 2023-05-25 06:30 pm | Q3 2023 Earnings Call |
| 2023-04-27 08:24 pm | March 2023 Sales and Revenue Release - Activities Report |
| 2023-02-27 04:30 pm | Q2 2023 Earnings Call |
| 2023-02-27 04:10 pm | Q2 2023 Earnings Release |
| 2023-02-14 | American Society for Transplantation and Cellular Therapy Tandem Meeting |
| 2023-01-31 02:22 am | December 2022 Sales and Revenue Release - Activities Report |
| 2022-11-22 | Annual General Meeting |
| 2022-11-22 04:49 pm | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 24,8 23,4 6.13% | 44,6 61,7 -27.8% | 10,2 42,6 -76% | 14,8 27,5 -45.97% | 11,6 12,8 -9.48% | 11,5 |
|
EBITDA Million AUD | Released Forecast Spread | -116 -144 19.78% | -97,4 -86,7 -12.33% | -116 -101 -15.08% | -102 -95,6 -6.24% | -89,1 -105 15.4% | -61,5 |
|
EBIT Million AUD | Released Forecast Spread | -119 -135 11.76% | -102 -90,3 -13.51% | -122 -102 -19.05% | -108 -96,8 -11.46% | -95,4 -112 14.7% | -76,5 |
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -147 -151 2.55% | -121 -107 -12.64% | -137 -102 -34.05% | -133 -117 -13.77% | -126 -133 4.77% | -103 |
|
Net income Million AUD | Released Forecast Spread | -133 -136 1.72% | -108 -97,1 -11.06% | -135 -106 -27.9% | -133 -119 -11.59% | -126 -133 5.27% | -103 |
|
EPS AUD | Released Forecast Spread | -0,54 -0,56 3.19% | -0,41 -0,36 -12.28% | -0,45 -0,25 -76.32% | -0,41 -0,19 -113.8% | -0,34 -0,17 -102.99% | -0,11 |
| Announcement Date | 29/08/19 | 26/08/20 | 30/08/21 | 30/08/22 | 30/08/23 | - |
Quarterly results
| Fiscal Period | June | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million AUD | Released Forecast Spread | 29,3 31,7 -7.8% | 18,0 17,7 1.68% | 4,60 4,44 3.52% | 5,36 5,51 -2.78% | 3,34 3,94 -15.23% | 2,81 14,1 -80.08% | 3,23 14,4 -77.52% | 6,16 7,29 -15.57% | 2,27 5,10 -55.52% | 3,17 3,04 4.39% | 5,41 5,80 -6.78% | 2,98 3,20 -6.77% | 3,29 3,62 -8.94% | 5,95 8,90 -33.12% | 0,00 | 5,76 | 5,22 5,67 -7.99% | 0,00 | 6,61 | 4,00 | 0,00 | 5,84 | 5,61 | 0,00 | 6,23 | |
|
EBITDA Million AUD | Released Forecast Spread | -39,9 -36,1 -10.67% | -61,1 -68,3 10.51% | -58,2 -77,3 24.71% | -54,4 -45,1 -20.75% | -52,6 -51,1 -2.97% | -47,1 -42,3 -11.43% | -42,6 -51,1 16.69% | -45,0 -53,6 15.91% | -30,6 -41,1 25.51% | |||||||||||||||||
|
EBIT Million AUD | Released Forecast Spread | -42,5 -38,7 -9.76% | -63,9 -70,7 9.71% | -60,8 -79,5 23.46% | -57,5 -48,2 -19.51% | -29,0 -32,9 12.08% | -55,7 -54,2 -2.64% | -24,3 -19,5 -24.57% | -24,9 -13,1 -90.89% | -50,3 -47,9 -4.85% | -18,8 -30,2 37.76% | -27,3 -26,8 -2.07% | -45,8 -56,6 19.02% | -21,0 -32,4 35.11% | -27,0 -29,5 8.7% | -49,4 -63,9 22.78% | -26,7 | -27,8 | -34,4 -44,2 22.21% | -42,3 | -44,1 | -45,9 | |||||
|
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -73,4 -81,1 9.55% | -66,0 -79,3 16.77% | -66,8 -31,5 -112.18% | -36,5 -35,9 -1.54% | -29,8 -21,4 -39.46% | -31,2 -15,0 -108.54% | -62,3 -54,9 -13.33% | -25,6 -36,7 30.44% | -36,5 -30,4 -19.95% | -61,7 -65,6 5.95% | -28,7 -39,5 27.47% | -33,8 -35,3 4.32% | -63,9 -81,1 21.22% | -26,7 | -27,8 | -50,3 -55,8 9.92% | -57,7 | -59,7 | -64,2 | |||||||
|
Net income Million AUD | Released Forecast Spread | -45,9 -45,7 -0.28% | -66,2 -68,7 3.7% | -65,1 -78,5 17.09% | -66,6 -48,2 -38.08% | -36,4 -35,9 -1.22% | -29,7 -20,8 -42.59% | -31,2 -18,7 -66.34% | -62,1 -49,1 -26.49% | -25,5 -36,7 30.66% | -36,4 -30,4 -19.67% | -61,5 -65,3 5.72% | -28,6 -39,5 27.61% | -33,8 -35,3 4.49% | -62,4 -77,2 19.17% | -26,7 | -27,8 | -50,1 -55,5 9.72% | -57,7 | -59,7 | -64,2 | ||||||
|
EPS AUD | Released Forecast Spread | -0,21 -0,07 -202.69% | -0,11 -0,14 18.71% | -0,10 -0,06 -66.72% | -0,10 -0,04 -124.41% | -0,17 -0,10 -77.66% | -0,08 -0,17 53.02% | -0,09 -0,07 -26.35% | -0,06 -0,06 6.79% | -0,06 | -0,06 | -0,06 | |||||||||||||||
| Announcement Date | 26/02/20 | 26/08/20 | 26/02/21 | 30/08/21 | 24/02/22 | 24/02/22 | 01/06/22 | 30/08/22 | 30/08/22 | 22/11/22 | 27/02/23 | 27/02/23 | 25/05/23 | 30/08/23 | 30/08/23 | - | - | 28/02/24 | - | - | - | - | - | - | - | - |
More events
Past sector events for Mesoblast Limited
| Today | PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release |
| Today | HANGZHOU TIGERMED CONSULTING CO., LTD: Q1 2024 Earnings Release |
| Today | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
| 2024-04-24 04:15 pm | ICON PUBLIC LIMITED COMPANY: Q1 2024 Earnings Release |
| 2024-04-24 10:21 am | SYNGENE INTERNATIONAL LIMITED: Q4 2024 Earnings Release |
| 2024-04-24 07:06 am | CUREVAC N.V.: Q4 2023 Earnings Release |
| 2024-04-24 01:45 am | ADDLIFE AB: Q1 2024 Earnings Release |
| 2024-04-24 01:00 am | EVOTEC SE: Q4 2023 Earnings Release |
| 2024-04-23 | SINO BIOLOGICAL,INC.: Q4 2023 Earnings Release |
| 2024-04-23 | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MSB Stock
- Calendar Mesoblast Limited
